2024 HCPCS Code Q5117

Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

Short Description	Inj., kanjinti, 10 mg
HCPCS Coverage Code	C - Carrier judgment
HCPCS Action Code	N - No maintenance for this code
HCPCS Action Effective Date	October 01, 2019
HCPCS Code Added Date	October 01, 2019
HCPCS Pricing Indicator Code	51 - Drugs
HCPCS Multiple Pricing Indicator Code	A - Not applicable as HCPCS priced under one methodology
HCPCS Coverage Issues Manual Reference Section Number
HCPCS Type Of Service Code	1 - Medical care
HCPCS Anesthesia Base Unit Quantity	0

Check Similar HCPCS Codes

• Q4311 - Acesso, per sq cm
• Q4312 - Acesso ac, per sq cm
• Q4313 - Dermabind fm, per sq cm
• Q4314 - Reeva, per sq cm
• Q4315 - Regenelink amniotic mem allo
• Q4316 - Amchoplast, per sq cm
• Q4317 - Vitograft, per sq cm
• Q4318 - E-graft, per sq cm
• Q4319 - Sanograft, per sq cm
• Q4320 - Pellograft, per sq cm
• Q4321 - Renograft, per sq cm
• Q4322 - Caregraft, per sq cm
• Q4323 - Alloply, per sq cm
• Q4324 - Amniotx, per sq cm
• Q4325 - Acapatch, per sq cm
• Q4326 - Woundplus, per sq cm
• Q4327 - Duoamnion, per sq cm
• Q4328 - Most, per sq cm
• Q4329 - Singlay, per sq cm
• Q4330 - Total, per sq cm